奈米生物科技的全球市场 2023

Nanobiotechnology

出版日期: 2023年03月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 212 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

奈米生物科技的全球市场到2030年将达到1,603亿美元

在COVID-19后改变的商务环境中，2022年1048亿美元的奈米生物科技的全球市场，在2022年～2030年间预计将以年复合成长率5.5％增长，2030年达到1603亿美元的规模。本报告所分析的市场区隔之一的医药品·生物科技产业，年复合成长率将记录6.3％，到分析期间结束时达到1103亿美元。考虑疫情后的復苏，医疗设备领域今后8年的年复合成长率将修正为3.9％。

美国市场估算为306亿美元，中国则将以年复合成长率4.8％增长

美国的奈米生物科技市场在2022年估算为306亿美元。作为世界第2大经济大国的中国，在从2022年到2030年的分析期间年复合成长率预计将为4.8％，2030年之前达到276亿美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年间预计将各以4.9％和3.3％的速度成长。在欧洲市场中，德国以年复合成长率3.5％成长。

调查对像企业范例

Ablynx NV
Arrowhead Pharmaceuticals Inc.
CaPtivate Pharmaceuticals LLC
Celgene Corporation
ELITechGroup
Flamel Technologies SA
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co. Inc.
NanoBio(R)Corporation
Nanophase Technologies Corporation
pSivida Corp.
Sigma-Aldrich Corp.
Starpharma Holdings Ltd.
Vectura Group plc

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nanobiotechnology Market to Reach $160.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nanobiotechnology estimated at US$104.8 Billion in the year 2022, is projected to reach a revised size of US$160.3 Billion by 2030, growing at aCAGR of 5.5% over the period 2022-2030. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$110.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Medical Devices segment is readjusted to a revised 3.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $30.6 Billion, While China is Forecast to Grow at 4.8% CAGR

The Nanobiotechnology market in the U.S. is estimated at US$30.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Select Competitors (Total 79 Featured):

Ablynx NV
Arrowhead Pharmaceuticals Inc.
CaPtivate Pharmaceuticals LLC
Celgene Corporation
ELITechGroup
Flamel Technologies SA
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co. Inc.
NanoBio® Corporation
Nanophase Technologies Corporation
pSivida Corp.
Sigma-Aldrich Corp.
Starpharma Holdings Ltd.
Vectura Group plc

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- A Curtain Raiser
- Recent Market Activity
- Nanobiotechnology - The Next Big Thing
- An Insight into the Global Nanobiotechnology Market
- Major Market Drivers
- Where Conventional Molecular Science Falls Short…Nanobio Steps In
- Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector
- Nanomedicine Market to Achieve Phenomenal Growth
- Opportunities Galore for Nanomedicine
- Drug Delivery - A Promising Application Area for Nanotechnology
- Nanotechnology Offers Huge Potential in Brain Disorder Treatment
- High Demand for Nanobots and Nano Healthcare Devices
- Nanotechnology Gaining Prominence for Treatment of Cancer
- Nanotechnology in Drug Delivery: A Specialized Market Opportunity
- Commercialization of Nanotechnology-based Medical Products Gains Momentum
- Nanodiagnostic Products to Witness Strong Demand Growth
- Dendrimers Serve as a Base to Build Multifunctional Nanodevices
- Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
- Huge Opportunities for Nanomaterials in the Medical Field
- Commercial Opportunities in Healthcare Sector
- Future Possibilities
- Global Market for Fullerenes - An Insight
- Dawn Breaks on Nanobiotechnology
- Demystifying the Intriguing World of Nanobiotech
- A Meeting Place of Medicine's Best Solutions
- Nanobiotechnology to Become Viable for All Drug Development Stages
- Nanoparticles: The Foundation of Nanobiotechnology
- Improved Optical Properties and Stability of Nanoparticles
- Nanoemulsions
- The Promise of Nanobiotechnology
- Biological Weaponries against Diseases Come in Small Packages
- Proffered Benefits of Nanobiotechnology
- Opportunity & Beyond
- Nanobiotechnology - Will it Live Up to the Expectations?
- The Future of Nanobiotechnology: Shape of Things to Come
- Nanobiotechnology: The Outer Limits
- Futuristics: A Rumination
- Conclusions
- Nanobiotechnology - Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
- Ablynx NV (Belgium)
- Arrowhead Pharmaceuticals, Inc. (USA)
- Avadel Pharmaceuticals plc (Ireland)
- CaPtivate Pharmaceuticals LLC (USA)
- Celgene Corporation (USA)
- ELITechGroup (France)
- GlaxoSmithKline Plc. (UK)
- Johnson & Johnson (USA)
- Merck & Co., Inc. (USA)
- NanoBio® Corporation (USA)
- Nanophase Technologies Corporation (USA)
- pSivida Corp. (USA)
- Sigma-Aldrich Corp. (USA)
- Starpharma Holdings Ltd. (Australia)
- Vectura Group plc (UK)
3. MARKET TRENDS & DRIVERS
- Present Status and Future Opportunities
- Outlook
- Developing Countries to Rise over the Horizon
- Nanomaterials & Nanoparticles Witness Robust Activity
- Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials
- Why Invest in Nanobiotechnology?
- Private and Public Companies to Step Up Funding on Nanotechnology
- United States Lead the Way in Government Funding
- Increasing Awareness on Technology to Drive Growth
- Demand for Novel Products to Push Up Growth
- Nano-Enabled Drug Discovery Holds Tremendous Potential
- Consolidation Sharpens the Industry's Edge
- The Regulatory Framework Evolves with the Technology
- Quantum Dot Patents Pose Legal Tangles
- Miniaturized Liquid Handling Becomes Progressive
- Trends in Nanotechnology Enabled Drug Delivery Systems
- Patent Expiries: A Key Driver
- Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 2: World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 3: World 16-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 5: World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 6: World 16-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 8: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 9: World 16-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- TABLE 10: World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- TABLE 11: USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 12: USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 13: USA 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 15: Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 16: Canada 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
JAPAN
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- TABLE 17: Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 18: Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 19: Japan 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
CHINA
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- TABLE 20: China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 21: China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 22: China 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
EUROPE
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- TABLE 23: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 24: Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 25: Europe 16-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
- TABLE 26: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 28: Europe 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
FRANCE
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- TABLE 29: France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 30: France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 31: France 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
GERMANY
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- TABLE 32: Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 33: Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 34: Germany 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
ITALY
- TABLE 35: Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 36: Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 37: Italy 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- TABLE 38: UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 39: UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 40: UK 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
REST OF EUROPE
- TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 42: Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 43: Rest of Europe 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 45: Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 46: Asia-Pacific 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030
REST OF WORLD
- TABLE 47: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 48: Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- TABLE 49: Rest of World 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2023 & 2030